141 related articles for article (PubMed ID: 7426028)
1. Studies with a 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP)-resistant L1210 leukemia cell line without cross-resistance to methotrexate.
Browman GP; Gorka C; Mehta C; Lazarus H; Abelson HT
Biochem Pharmacol; 1980 Aug; 29(16):2241-5. PubMed ID: 7426028
[No Abstract] [Full Text] [Related]
2. The intracellular mechanism of action of metoprine (DDMP).
Browman GP; Calvert AH; Taylor GA; Hart LI; Harrap KR
Eur J Cancer (1965); 1980 Dec; 16(12):1547-54. PubMed ID: 6971755
[No Abstract] [Full Text] [Related]
3. Combination antifol therapy: observations on the development of resistant L1210 leukemic cells in vivo.
Browman GP; Lazarus H
Cancer Treat Rep; 1980; 64(2-3):231-6. PubMed ID: 7407755
[TBL] [Abstract][Full Text] [Related]
4. Development of drug derivatives without cross-resistance to parent compounds.
Scheulen ME
Cancer Treat Rev; 1990 Dec; 17 Suppl A():67-79. PubMed ID: 1965493
[No Abstract] [Full Text] [Related]
5. Human plasma and amino acids as moderators of uptake and metabolic consequences of antifolates in WIL-2 and human leukemia cells.
Fyfe MJ; Sedwick WD; Brown OE; Laszlo J
J Natl Cancer Inst; 1981 Mar; 66(3):445-51. PubMed ID: 6937701
[TBL] [Abstract][Full Text] [Related]
6. Studies concerned with overcoming resistance to methotrexate: a comparison of the effects of methotrexate and 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (BW50197) on the colony forming ability of L5178Y cells.
Hill BT; Goldie JH; Price LA
Br J Cancer; 1973 Sep; 28(3):263-8. PubMed ID: 4743908
[TBL] [Abstract][Full Text] [Related]
7. New dose-time relationships of folate antagonists to sustain inhibition of human lymphoblasts and leukemic cells in vitro.
Sedwick WD; Kutler M; Frazer T; Brown OE; Laszlo J
Cancer Res; 1979 Sep; 39(9):3612-8. PubMed ID: 314333
[TBL] [Abstract][Full Text] [Related]
8. Selective toxicity of a new lipophilic antifolate, BW301U, for methotrexate-resistant cells with reduced drug uptake.
Taylor IW; Slowiaczek P; Friedlander ML; Tattersall MH
Cancer Res; 1985 Mar; 45(3):978-82. PubMed ID: 3971388
[TBL] [Abstract][Full Text] [Related]
9. Crystallographic studies of the antineoplastic antifolate 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP) ethanesulfonate salt.
Cody V
Cancer Biochem Biophys; 1983; 6(3):173-7. PubMed ID: 6850552
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of methotrexate and metoprine: metabolic toxicity and cell killing.
Sedwick WD; Fyfe MJ; Hamrell M; Laszlo J
Adv Enzyme Regul; 1978; 17():399-416. PubMed ID: 294129
[No Abstract] [Full Text] [Related]
11. The role of methionine in methotrexate-sensitive and methotrexate-resistant mouse leukemia L1210 cells.
Scanlon KJ; Kashani-Sabet M; Cashmore AR; Pallai M; Moroson BA; Saketos M
Cancer Chemother Pharmacol; 1987; 19(1):25-9. PubMed ID: 3815722
[TBL] [Abstract][Full Text] [Related]
12. An enzyme inhibition assay for 2,4-diamino-5-(3'4'-dichlorophenyl)-6-methylpyrimidine (DDMP,NSC 19494).
Calvert AH; Cridland JS; Harrap KR
J Clin Pathol; 1977 Dec; 30(12):1154-7. PubMed ID: 604362
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibitory, transport and biochemical properties of the gamma-glutamyl and gamma-aspartyl peptides of methotrexate in L1210 leukemia cells in vitro.
Sirotnak FM; Chello PL; Piper JR; Montgomery JA
Biochem Pharmacol; 1978; 27(14):1821-5. PubMed ID: 708463
[No Abstract] [Full Text] [Related]
14. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
[TBL] [Abstract][Full Text] [Related]
15. Lethal and kinetic effects of DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine).
Hill BT
Eur J Cancer (1965); 1980 Jan; 16(1):147-57. PubMed ID: 6987066
[No Abstract] [Full Text] [Related]
16. DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-methylpyrimidine).
Hill BT; Price LA
Cancer Treat Rev; 1980 Jun; 7(2):95-112. PubMed ID: 6996812
[No Abstract] [Full Text] [Related]
17. Biochemical correlates of responsiveness and collateral sensitivity of some methotrexate-resistant murine tumors to the lipophilic antifolate, metoprine.
Sirotnak FM; Moccio DM; Goutas LJ; Kelleher LE; Montgomery JA
Cancer Res; 1982 Mar; 42(3):924-8. PubMed ID: 7059991
[TBL] [Abstract][Full Text] [Related]
18. Deoxyuridine incorporation as a useful measure of methotrexate and metoprine uptake and metabolic effectiveness.
Sedwick WD; Fyfe MJ; Brown OE; Frazer TA; Kutler M; Laszlo J
Mol Pharmacol; 1979 Sep; 16(2):607-13. PubMed ID: 514260
[No Abstract] [Full Text] [Related]
19. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
Jackman AL; Alison DL; Calvert AH; Harrap KR
Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
[TBL] [Abstract][Full Text] [Related]
20. A fluorescent derivative of methotrexate as an intracellular marker for dihydrofolate reductase in L1210 cells.
Henderson GB; Russell A; Whiteley JM
Arch Biochem Biophys; 1980 Jun; 202(1):29-34. PubMed ID: 6772112
[No Abstract] [Full Text] [Related]
[Next] [New Search]
